Education:

Duke University: Biology, B.S.

Baylor College of Medicine: Integrative Molecular and Biomedical Sciences, Ph.D.

About:

Dr. Ken Fujiwara currently serves as a Regulatory Affairs Associate at Proxima Clinical Research, Inc. Proxima is a contract research organization focused on assisting emerging pharmaceutical and medical device companies in clinical product development. He has contributed to a wide range of regulatory and clinical projects for clients in both the medical device and pharmaceutical drug fields, including Breakthrough Device Designation applications, Pre-Submission Meeting requests, 510K submissions, CE Mark applications, Clinical Trial protocols and IND submissions.

Dr. Fujiwara regularly provides QC and document review for the entire regulatory team and also handles drug and medical device submissions to the FDA.

Positions and Honors:

Proxima Clinical Research, Inc., Houston, Texas
Regulatory Affairs Associate/Regulatory Document Specialist/Regulatory Intern (Paid)

Baylor College of Medicine, Integrative Molecular and Biomedical Sciences, Houston, Texas
PhD Candidate

Duke University, Center for Applied Genome Technology, Durham, North Carolina
Research Technician II

Duke University, Morris K. Udall Parkinson Disease Research Center of Excellence, Durham, North Carolina
Research Technician II

Pharmacia/Monsanto Life Sciences, Inc., Nutrition and Consumer Products Division, Creve Coeur, Missouri
Summer Intern (Paid)

Pharmacia/Monsanto Life Sciences, Inc., Searle/Pharmaceuticals Division, Chesterfield, Missouri
Summer Intern (Paid)

Washington University School Of Medicine/University Of Missouri-St. Louis, Engelmann Scholar Research Program, St. Louis, Missouri
Engelmann Scholar

Contributions to Science:

Dr. Fujiwara has played an important role in the development of the following medical products:

  1. Biologic- Oncolytic Adenovirus
  2. Drug- Endovascular Tissue Repair
  3. Medical Device- Infectious Disease Diagnostic Device  
  4. Medical Device- Implanted oncological catheter
  5. Medical Device- COVID-19 diagnostic
  6. Medical Device- Wearable health monitor
  7. Medical Device- Wearable cardiac monitor
  8. Medical Device- Machine-learning CT scan evaluator
  9. Medical Device- Resorbable aortic stent

Dr. Fujiwara has contributed to the following publications:    

Choi B, Fujiwara K*, Dayaram T, Darlington Y, Dickerson J, Goodell MA, Donehower LA. WIP1 dephosphorylation of p27Kip1 Serine 140 destabilizes p27Kip1 and reverses anti-proliferative effects of ATM phosphorylation. Cell Cycle. 2020 Feb;19(4):479-491.  

*Co-First Author Publication  

Fujiwara K, Yuwanita I, Hollern DP, Andrechek ER.  Prediction and genetic demonstration of a role for activator E2Fs in Myc induced tumors. Cancer Research. 2011 Mar 1;71(5):1924-32.  

Hancock DB, Martin ER, Fujiwara K, Stacy MA, Scott BL, Stajich JM, Jewett R, Li Y, Hauser MA, Vance JM, Scott WK. NOS2A and the modulating effect of cigarette smoking in Parkinson’s disease. Annals of Neurology. 2006 Sep;60(3):366-73.  

Kang SJ, Scott WK, Li Y, Hauser MA, Van Der Walt JM, Fujiwara K, Mayhew GM, West SG, Vance JM, Martin ER. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. Movement Disorders. 2006 Dec;21(12):2175-2180.

Oliveira SA, Scott WK, Zhang F, Stajich JM, Fujiwara K, Hauser M, Scott BL, Pericak-Vance MA, Vance JM, Martin ER. Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype. Neurogenetics. 2004 Sep;5(3):147-55.  

Van Der Walt JM, Noureddine MA, Kittappa R, Hauser MA, Scott WK, McKay R, Zhang F, Stajich JM, Fujiwara K, Scott BL, Pericak-Vance MA, Vance JM, Martin ER. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. American Journal of Human Genetics. 2004 Jun;74(6):1121-7.  

Van Der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen Jr FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Roses AD, Stajich JM, Booze MW, Fujiwara K, Gibson RA, Middleton LT, Scott BL, Pericak-Vance MA, Vance JM. Genetic polymorphisms of the N-acetyltransferase genes (NAT1 and NAT2) and risk to Parkinson's disease. Neurology. 2003 Apr 8;60(7):1189-91.  

Additional Information:

Dr. Fujiwara earned a certificate for Life Science Entrepreneurship from Rice University in May of 2016.  

OriginallY From:
St. Louis, Missouri
Fun Fact:
Ken has played the cello since he was 5 years old and is currently an active member of the Texas Medical Center Orchestra. With TMCO, Ken participated in a global musical collaboration for the United Nations Foundation COVID-19 Solidarity Response Fund, which recently earned a mention on Billboard.com.
Recent Updates
Knowledge Base Contributions
Frequently Asked Questions
Glossary Terms